Matthew Gall - Insider Trading & Ownership

Entity
Individual
Location
C/O Iteos Therapeutics, Inc., 139 Main Street, Cambridge, MA
Summary
The estimated net worth of Matthew Gall is at least $506K dollars as of November 19, 2024. Matthew Gall is the Chief Financial Officer of iTeos Therapeutics, Inc. and owns shares of iTeos Therapeutics, Inc. (ITOS) stock worth about $506K.
All Insider Reports
All Insider Reports

Ownership of Matthew Gall

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
ITOS iTeos Therapeutics, Inc. Chief Financial Officer $506K +$38.6K +8.27% Nov 19, 2024

Insider Transactions Reported by Matthew Gall:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.